Clinical Trials Logo

Filter by:
NCT ID: NCT05854524 Not yet recruiting - Parkinson Disease Clinical Trials

Exercise Neuroprotection in Parkinson's Disease

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This purpose of this study is to explore the relationships of exercise on inflammation in the body in older adults and people with Parkinson's disease (PD). This is important research for older adults and but is especially important for people with PD because neuroinflammation is the main pathological mechanism that is responsible for neuron cell death in this neurodegenerative disease. As PD is a progressive disease, halting or slowing the degeneration is an important research target. Halting or slowing the disease progress is known as neuroprotection. Exercise is an attractive therapeutic treatment for people with PD as it has a lot of multi-systemic benefits but also there is a lot of evidence to suggest that it helps improve symptoms and slow the progression of the disease. Exercise has been theorized to decreased inflammation and, therefore, has a lot of promise as a neuroprotective agent in slowing or halting the degeneration in PD. Unfortunately, there is not a lot of research that has looked into the effect of exercise on the biological processes of inflammation. Thus, the purpose of this study is to investigate the biological evidence that underlies the positive effect of exercise in people with PD.

NCT ID: NCT05853614 Not yet recruiting - Quality of Life Clinical Trials

Nurse-Led Quality of Life Study-Phase I

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to pilot test a brief, population-specific nurse-led, quality of life (QOL) intervention with early phase cancer clinical trial (EP-CT) participants. The name of the intervention used in this research study is: -Nurse-Led Quality of Life Intervention (comprised of nurse-patient relationship, assessment and monitoring of participant QOL, and interdisciplinary team meetings led by the CRN (clinical research nurse).

NCT ID: NCT05852587 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Start date: January 1, 2025
Phase: Phase 1
Study type: Interventional

This is a randomized, placebo-controlled, dose-ranging study to assess the safety and efficacy of xylitol as an oral therapeutic for decolonization of C. difficile in IBD patients. A total of 99 patients who meet eligibility criteria will be randomized 1:1:1 to one of two xylitol doses or placebo arm. All arms will receive an identical capsule dosing for four weeks. Microbiome assessment and C. difficile testing will be performed at baseline, week 4, 8, 26, and 52.

NCT ID: NCT05851846 Not yet recruiting - Long COVID Clinical Trials

Amygdala Insula Retraining in the Management of Long COVID Symptoms

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

The goal of the study is to compare a mind body intervention against usual care in patients with fatigue with long COVID. Our research questions include 1. Is the mind body intervention additive to usual care in long COVID 2. Can the mind body intervention change laboratory markers, heart rate variability and dysautonomia.

NCT ID: NCT05849142 Not yet recruiting - Oropharynx Cancer Clinical Trials

Feasibility of Adaptive Radiation Therapy for Human-papilloma Virus-positive Oropharyngeal Cancer Patients on MRIdian Linac

OPC-V
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to determine whether it is feasible to treat patients with Human Papilloma Virus positive (HPV-positive) oropharyngeal tumors on a specialized treatment machine (MRIdian linear accelerator [Linac]), which utilizes magnetic resonance imaging (MRI) for radiation planning and delivery.

NCT ID: NCT05848856 Not yet recruiting - Breast Cancer Risk Clinical Trials

The RISC Registry--Risk Informed Screening Registry

RISC
Start date: June 1, 2023
Phase:
Study type: Observational

Health inequities are defined as systemic differences in the health status of different population groups. It is well established that there are many sources of health inequity in oncology including differences in mortality, cancer screening uptake, time to diagnosis and disparities in access to treatment and care. Routine cancer screening and effective surveillance and follow up are some of the most effective ways to reduce the burden of cancer across an individual's lifetime and at the population level. While there is a lack of screening tests for many cancers, breast cancer, the second highest leading cause of cancer death in women, has a plethora of validated screening and risk reduction approaches which can yield earlier detection and effective ways of treating and following women at risk and with breast cancer and improve outcomes. However, there is uneven adoption and inconsistent use of these technologies and care practices. The RISC Registry is an observational study that seeks to understand the application of risk-informed screening and care approaches and pursue the hypothesis that these screening approaches accompanied by population appropriate methods of clinician and patient engagement may increase understanding and compliance with screening, surveillance and follow up recommendations by empowering people to make healthier choices, and support addressing disparities in screening and patient care. The primary focus is cancer screening with a focus on Precision Screening. (Precision Screening attempts to separate those who will benefit from screening from those that may not, through use of information on disease risk.) The study will start by focusing on women and breast cancer risk.

NCT ID: NCT05848297 Not yet recruiting - Clinical trials for Brain Injuries, Traumatic

Automated Robotic TCD in Traumatic Brain Injury

ART-TBI
Start date: June 20, 2024
Phase:
Study type: Observational

This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience

NCT ID: NCT05848232 Not yet recruiting - Coronary Occlusion Clinical Trials

Single-Arm Study Evaluating Use of the CORA Catheters for the Crossing of Coronary Chronic Total Occlusions

Cora CTO
Start date: June 2024
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and effectiveness of the coraFlex, coraForce, and coraCross catheters for crossing chronic total occlusions of the coronary arteries. The study will compare the rate of procedure success to success rates from previous trials. Participants will undergo percutaneous coronary intervention (PCI) for a chronic total occlusion and be followed for 30 days post-procedure.

NCT ID: NCT05846880 Not yet recruiting - Multiple Myeloma Clinical Trials

VitD3 Supplementation in Patients With Multiple Myeloma

Start date: April 2024
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate post-transplant immune reconstitution and lymphocyte recovery as well as the 3-year progression-free survival of patients with multiple myeloma in two treatment arms. One arm will receive lenalidomide and an intensified regimen of maintenance VitD, and the other arm will receive lenalidomide and a therapeutic regimen of VitD. This clinical trial will also evaluate the overall response rate and survival for both treatment arms.

NCT ID: NCT05846802 Not yet recruiting - Gastroparesis Clinical Trials

Gastroparesis Registry 4

GpR4
Start date: June 30, 2024
Phase:
Study type: Observational

The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.